![Manish S Bhandare (@manishbhandare4) 's Twitter Profile](https://pbs.twimg.com/profile_images/1536386197026635780/whrvzs-9_200x200.jpg)
Manish S Bhandare
@manishbhandare4
GI & HPB surgeon and Professor, TATA Memorial Hospital, Mumbai, India.
ID: 743858283929165826
17-06-2016 17:30:09
1,1K Tweet
3,3K Followers
351 Following
![JAMA Surgery (@jamasurgery) 's Twitter Profile Photo JAMA Surgery (@jamasurgery) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1117875087619891202/pb6vCirz_200x200.png)
![anand mahindra (@anandmahindra) 's Twitter Profile Photo anand mahindra (@anandmahindra) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1660212046779252737/fwUV5epW_200x200.jpg)
![Anant Ramaswamy (@anantramaswamy) 's Twitter Profile Photo Anant Ramaswamy (@anantramaswamy) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1268057302847746050/o0xfdCnB_200x200.jpg)
Select your patients with periamp cancers for adjuvant therapy- A match-pair analysis from 8 institutions (The MIPPAP study) - HPB hpbonline.org/article/S1365-ā¦ Shailesh V. Shrikhande Manish S Bhandare bhawna sirohi @SupriyaChopra Viraj Lavingia
![Gurudutt P. Varty (@drguruduttvarty) 's Twitter Profile Photo Gurudutt P. Varty (@drguruduttvarty) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1658856184684879872/j6Mh9m2y_200x200.jpg)
Manish S Bhandare Annals of Surgery Shailesh V. Shrikhande Tata Memorial Hospital Dr.Vikram Chaudhari Anant Ramaswamy Prabhat Bhargava, DM (Medical Oncology) Akshay Baheti Subhash Yadav Dr.RaviChandra Reddy Factors for poor OS T stage, Margin +, LN +, PNI, poor diff, PB subtype Factors for poor RFS T stage, LN +, poor diff, PNI, adj tissue invol Recurrences high [251/572 (61.7%), distant > local) Adjuvant therapy benefits 5-year OS (adj vs no adj) - 40.4%, vs. 32.3% (p ā 0.012)
![Gurudutt P. Varty (@drguruduttvarty) on Twitter photo <a href="/Manishbhandare4/">Manish S Bhandare</a> <a href="/AnnalsofSurgery/">Annals of Surgery</a> <a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> <a href="/TataMemorial/">Tata Memorial Hospital</a> <a href="/DrVAChaudhari/">Dr.Vikram Chaudhari</a> <a href="/AnantRamaswamy/">Anant Ramaswamy</a> <a href="/bhargava611/">Prabhat Bhargava, DM (Medical Oncology)</a> <a href="/Dr_AkshayBaheti/">Akshay Baheti</a> <a href="/Subhash_YadavMD/">Subhash Yadav</a> <a href="/DrRaviChandra/">Dr.RaviChandra Reddy</a> Factors for poor OS
T stage, Margin +, LN +, PNI, poor diff, PB subtype
Factors for poor RFS
T stage, LN +, poor diff, PNI, adj tissue invol
Recurrences high [251/572 (61.7%), distant > local)
Adjuvant therapy benefits
5-year OS (adj vs no adj) - 40.4%, vs. 32.3% (p ā 0.012) <a href="/Manishbhandare4/">Manish S Bhandare</a> <a href="/AnnalsofSurgery/">Annals of Surgery</a> <a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> <a href="/TataMemorial/">Tata Memorial Hospital</a> <a href="/DrVAChaudhari/">Dr.Vikram Chaudhari</a> <a href="/AnantRamaswamy/">Anant Ramaswamy</a> <a href="/bhargava611/">Prabhat Bhargava, DM (Medical Oncology)</a> <a href="/Dr_AkshayBaheti/">Akshay Baheti</a> <a href="/Subhash_YadavMD/">Subhash Yadav</a> <a href="/DrRaviChandra/">Dr.RaviChandra Reddy</a> Factors for poor OS
T stage, Margin +, LN +, PNI, poor diff, PB subtype
Factors for poor RFS
T stage, LN +, poor diff, PNI, adj tissue invol
Recurrences high [251/572 (61.7%), distant > local)
Adjuvant therapy benefits
5-year OS (adj vs no adj) - 40.4%, vs. 32.3% (p ā 0.012)](https://pbs.twimg.com/media/GUjQsfZa8AAYb8_.jpg)
![Gurudutt P. Varty (@drguruduttvarty) 's Twitter Profile Photo Gurudutt P. Varty (@drguruduttvarty) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1658856184684879872/j6Mh9m2y_200x200.jpg)
Manish S Bhandare Annals of Surgery Shailesh V. Shrikhande Tata Memorial Hospital Dr.Vikram Chaudhari Anant Ramaswamy Prabhat Bhargava, DM (Medical Oncology) Akshay Baheti Subhash Yadav Dr.RaviChandra Reddy How well did CA 19-9 perform in predicting recurrence? Static as well as dynamic CA 19-9 parameters used āSerial riseā or āfirst raised value > 200ā are almost always associated with recurrence Relative rise of CA 19-9 is an important dynamic parameter.
![Gurudutt P. Varty (@drguruduttvarty) on Twitter photo <a href="/Manishbhandare4/">Manish S Bhandare</a> <a href="/AnnalsofSurgery/">Annals of Surgery</a> <a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> <a href="/TataMemorial/">Tata Memorial Hospital</a> <a href="/DrVAChaudhari/">Dr.Vikram Chaudhari</a> <a href="/AnantRamaswamy/">Anant Ramaswamy</a> <a href="/bhargava611/">Prabhat Bhargava, DM (Medical Oncology)</a> <a href="/Dr_AkshayBaheti/">Akshay Baheti</a> <a href="/Subhash_YadavMD/">Subhash Yadav</a> <a href="/DrRaviChandra/">Dr.RaviChandra Reddy</a> How well did CA 19-9 perform in predicting recurrence?
Static as well as dynamic CA 19-9 parameters used
āSerial riseā or āfirst raised value > 200ā are almost always associated with recurrence
Relative rise of CA 19-9 is an important dynamic parameter. <a href="/Manishbhandare4/">Manish S Bhandare</a> <a href="/AnnalsofSurgery/">Annals of Surgery</a> <a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> <a href="/TataMemorial/">Tata Memorial Hospital</a> <a href="/DrVAChaudhari/">Dr.Vikram Chaudhari</a> <a href="/AnantRamaswamy/">Anant Ramaswamy</a> <a href="/bhargava611/">Prabhat Bhargava, DM (Medical Oncology)</a> <a href="/Dr_AkshayBaheti/">Akshay Baheti</a> <a href="/Subhash_YadavMD/">Subhash Yadav</a> <a href="/DrRaviChandra/">Dr.RaviChandra Reddy</a> How well did CA 19-9 perform in predicting recurrence?
Static as well as dynamic CA 19-9 parameters used
āSerial riseā or āfirst raised value > 200ā are almost always associated with recurrence
Relative rise of CA 19-9 is an important dynamic parameter.](https://pbs.twimg.com/media/GUjTgEZaYAAhCFA.jpg)
![Gurudutt P. Varty (@drguruduttvarty) 's Twitter Profile Photo Gurudutt P. Varty (@drguruduttvarty) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1658856184684879872/j6Mh9m2y_200x200.jpg)
Manish S Bhandare Annals of Surgery Shailesh V. Shrikhande Tata Memorial Hospital Dr.Vikram Chaudhari Anant Ramaswamy Prabhat Bhargava, DM (Medical Oncology) Akshay Baheti Subhash Yadav Dr.RaviChandra Reddy Rise in CA 19-9 precedes radiological recurrence by 4.04 months Recurrence detected by CA 19-9 rise -->Early therapy -->survival benefit Recurrence detection after CA 19-9 elevation has better survival than recurrence detection without elevation (12.8 vs 7.6 months, p ā 0.005)
![Gurudutt P. Varty (@drguruduttvarty) on Twitter photo <a href="/Manishbhandare4/">Manish S Bhandare</a> <a href="/AnnalsofSurgery/">Annals of Surgery</a> <a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> <a href="/TataMemorial/">Tata Memorial Hospital</a> <a href="/DrVAChaudhari/">Dr.Vikram Chaudhari</a> <a href="/AnantRamaswamy/">Anant Ramaswamy</a> <a href="/bhargava611/">Prabhat Bhargava, DM (Medical Oncology)</a> <a href="/Dr_AkshayBaheti/">Akshay Baheti</a> <a href="/Subhash_YadavMD/">Subhash Yadav</a> <a href="/DrRaviChandra/">Dr.RaviChandra Reddy</a> Rise in CA 19-9 precedes radiological recurrence by 4.04 months
Recurrence detected by CA 19-9 rise -->Early therapy -->survival benefit
Recurrence detection after CA 19-9 elevation has better survival than recurrence detection without elevation (12.8 vs 7.6 months, p ā 0.005) <a href="/Manishbhandare4/">Manish S Bhandare</a> <a href="/AnnalsofSurgery/">Annals of Surgery</a> <a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> <a href="/TataMemorial/">Tata Memorial Hospital</a> <a href="/DrVAChaudhari/">Dr.Vikram Chaudhari</a> <a href="/AnantRamaswamy/">Anant Ramaswamy</a> <a href="/bhargava611/">Prabhat Bhargava, DM (Medical Oncology)</a> <a href="/Dr_AkshayBaheti/">Akshay Baheti</a> <a href="/Subhash_YadavMD/">Subhash Yadav</a> <a href="/DrRaviChandra/">Dr.RaviChandra Reddy</a> Rise in CA 19-9 precedes radiological recurrence by 4.04 months
Recurrence detected by CA 19-9 rise -->Early therapy -->survival benefit
Recurrence detection after CA 19-9 elevation has better survival than recurrence detection without elevation (12.8 vs 7.6 months, p ā 0.005)](https://pbs.twimg.com/media/GUjTxTeWAAETck_.jpg)
![Shravan Nadkarni (@oncoshravan) 's Twitter Profile Photo Shravan Nadkarni (@oncoshravan) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1634470423546187778/CGt6_8GI_200x200.jpg)
BALCO Medical Centre, New Raipur is hosting d annual Cancer Conclave (September 20-22) Join us for Live surgery - Whipple Procedure & Radical Gastrectomy + D2 Lymphadenectomy by Prof Shailesh V. Shrikhande & Prof Manish S Bhandare from Tata Memorial Hospital, Mumbai. Reg link - t.ly/2mR0a
![Shravan Nadkarni (@oncoshravan) on Twitter photo <a href="/BalcoMedical/">BALCO Medical Centre</a>, New Raipur is hosting d annual Cancer Conclave (September 20-22)
Join us for Live surgery - Whipple Procedure & Radical Gastrectomy + D2 Lymphadenectomy by Prof <a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> & Prof <a href="/Manishbhandare4/">Manish S Bhandare</a> from <a href="/TataMemorial/">Tata Memorial Hospital</a>, Mumbai.
Reg link - t.ly/2mR0a <a href="/BalcoMedical/">BALCO Medical Centre</a>, New Raipur is hosting d annual Cancer Conclave (September 20-22)
Join us for Live surgery - Whipple Procedure & Radical Gastrectomy + D2 Lymphadenectomy by Prof <a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> & Prof <a href="/Manishbhandare4/">Manish S Bhandare</a> from <a href="/TataMemorial/">Tata Memorial Hospital</a>, Mumbai.
Reg link - t.ly/2mR0a](https://pbs.twimg.com/media/GU80QulbMAAZ4l9.jpg)
![sanket sharad mehta (@sanket86024322) 's Twitter Profile Photo sanket sharad mehta (@sanket86024322) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1233777486179295234/dtgwmwwY_200x200.jpg)
LAPC cases post-chemotherapy can pose significant challenges. In such situations, total pancreatectomy with vessel divestment may be the necessary option for salvage. Grateful to Shailesh V. Shrikhande Manish S Bhandare and their team for inspiring us to take on such complex cases.
![Deeksha Kapoor (@deekshakapoor1) 's Twitter Profile Photo Deeksha Kapoor (@deekshakapoor1) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1746543438001319936/S-j0Q3O2_200x200.jpg)
Itās time for āsite-specificā prediction of CR-POPF after PD! Our latest publication in the Annals of Surgery demonstrates that the 2-factor ISGPS Classification of High-Risk Pancreas underperforms in predicting the risk of CRPF in periampullary tumours. Shailesh V. Shrikhande
![Deeksha Kapoor (@deekshakapoor1) on Twitter photo Itās time for āsite-specificā prediction of CR-POPF after PD!
Our latest publication in the Annals of Surgery demonstrates that the 2-factor ISGPS Classification of High-Risk Pancreas underperforms in predicting the risk of CRPF in periampullary tumours.
<a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> Itās time for āsite-specificā prediction of CR-POPF after PD!
Our latest publication in the Annals of Surgery demonstrates that the 2-factor ISGPS Classification of High-Risk Pancreas underperforms in predicting the risk of CRPF in periampullary tumours.
<a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a>](https://pbs.twimg.com/media/GVWEWj7bAAEBWLo.jpg)
![Shravan Nadkarni (@oncoshravan) 's Twitter Profile Photo Shravan Nadkarni (@oncoshravan) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1634470423546187778/CGt6_8GI_200x200.jpg)
BALCO Medical Centre, New Raipur is hosting the Annual Cancer Conclave on Sep 20-22 2024. Live surgery by Shailesh V. Shrikhande & Manish S Bhandare Hands-on Workshops on Lap Bowel Suturing & HJ-PJ Anastomosis on porcine pancreas supported by Ethicon and conducted by Dr. Saneya
![Shravan Nadkarni (@oncoshravan) on Twitter photo <a href="/BalcoMedical/">BALCO Medical Centre</a>, New Raipur is hosting the Annual Cancer Conclave on Sep 20-22 2024.
Live surgery by <a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> & <a href="/Manishbhandare4/">Manish S Bhandare</a>
Hands-on Workshops on Lap Bowel Suturing & HJ-PJ Anastomosis on porcine pancreas supported by <a href="/Ethicon/">Ethicon</a> and conducted by <a href="/Saneya_2810/">Dr. Saneya</a> <a href="/BalcoMedical/">BALCO Medical Centre</a>, New Raipur is hosting the Annual Cancer Conclave on Sep 20-22 2024.
Live surgery by <a href="/Shrikhande_SV/">Shailesh V. Shrikhande</a> & <a href="/Manishbhandare4/">Manish S Bhandare</a>
Hands-on Workshops on Lap Bowel Suturing & HJ-PJ Anastomosis on porcine pancreas supported by <a href="/Ethicon/">Ethicon</a> and conducted by <a href="/Saneya_2810/">Dr. Saneya</a>](https://pbs.twimg.com/media/GV14fFubQAAeBZx.jpg)